In a May 7, 2024 press release, Seragon Biosciences announced that its aging intervention drug candidate, SRN-901, achieved one of the largest extensions of
Discover how Restorin, a cutting-edge nutraceutical backed by Harvard and Mayo Clinic research, promotes better sleep, energy, focus, and healthy aging.
Uncovering cancer-associated fibroblasts: the hidden architects of ovarian cancer’s defenses and the potential targets for overcoming treatment resistance.
Nanopore protein sequencing offers groundbreaking insights into how proteins age, driving advancements in longevity research and unlocking potential therapies for age-related diseases.
Cellular reprogramming holds the promise of reversing aging by resetting cells to a youthful state. Advances in this science could revolutionize longevity and healthspan.